LIBERATE clinical registry

LIBERATE: Clinical registry monitoring men after focal brachytherapy for prostate cancer

Purpose: To ensure appropriate selection of patients and quality assurance, the LIBERATE clinical registry has been developed which monitors men who have undergone focal brachytherapy for prostate cancer. The registry is Icon Cancer Centre initiated.

LIBERATE aims to provide proof of concept that focal brachytherapy minimises side effects that are commonly seen in treating the whole prostate for men with low to intermediate risk prostate cancer.

LIBERATE is the only registry monitoring patients who have undergone focal brachytherapy.

Location: Icon Cancer Centre Richmond and Icon Cancer Centre Freemasons

To be considered for the registry or for further information, please contact:

Dr Andrew See, Principal Investigator, Radiation Oncologist
Icon Cancer Centre Richmond, Epworth Healthcare
P 03 9936 8277 | F 03 9978 9427

A/Prof Jeremy Grummet, Co-Principal Investigator, Urologic Surgeon
Epworth Healthcare
P 03 8506 3646 | F 03 8506 3699

Starting radiation therapy

Knowing what to expect can help you prepare for your first radiation therapy visit.
Learn more

Radiation Oncologists

We have highly experienced radiation oncologists across Australia.
Learn more

Frequently asked questions

Learn answers to some common concerns and misconceptions about radiation therapy.
Learn more